Nexium Capsules RE Maintenance Specific Clinical Experience Investigation

AstraZeneca647 enrolled

Overview

The purpose of this study is to collect following data in patients given Nexium capsule (Nexium) in usual post-marketing use as the maintenance therapy for repeatedly recurring/relapsing reflux oesophagitis.

Nexium capsules Specific Clinical Experience Investigation for Maintenance Therapy for Repeatedly Recurring/Relapsing Reflux Oesophagitis

Study Type

OBSERVATIONAL

Enrollment

647

Conditions

Repeatedly Recurring Esophagitis Relapsing Reflux Esophagitis

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with repeatedly recurring/relapsing reflux oesophagitis who will be given Nexium for the first time as a maintenance therapy. Exclusion Criteria: * Patients having reflux oesophagitis when Nexium is started (Grade A, Grade B, Grade C or Grade D of Los Angeles Classification (Hoshihara's modification) on endoscopy) * Patients having previous history of maintenance therapy for repeatedly recurring/ relapsing reflux oesophagitis

Locations (46)

Outcomes

Primary Outcomes

Number of Adverse Drug Reactions

Adverse event incidence

Time frame: 6 Month

Secondary Outcomes

Non-recurrence rate of reflux oesophagitis

Time frame: 6 Month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Research Site

Aichi, Japan

Research Site

Akita, Japan

Research Site

Aomori, Japan

Research Site

Chiba, Japan

Research Site

Ehime, Japan

Research Site

Fukui, Japan

Research Site

Fukuoka, Japan

Research Site

Fukushima, Japan

Research Site

Gifu, Japan

Research Site

Gunma, Japan

...and 36 more locations